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ABSTRACT 
Aim: To characterize the production and application of carbohydrate functionalized poly(d,l -
lactide-co-glycolide) (PLGA) nanospheres as immune-modulatory mediators in the treatment 
of visceral leishmaniasis (VL). Materials & methods: PLGA nanospheres were prepared by 
nanoprecipitation and surface functionalized with mannose, mannan or mannosamine 
moieties using a carbodiimide reaction. Flow cytometry and fluorescence microscopy revealed 
the interaction of these nanospheres with macrophages. Results: The nanocarriers were 
taken up by murine primary macrophages using clathrin-mediated endocytosis. Co-culture of 
macrophages with carbohydrate-functionalized nanospheres led to their activation and 
production of pro-inflammatory cytokines. One dose of amphotericin B-loaded on mannan-
functionalized nanospheres resulted in an efficacy VL therapy. Conclusion: This approach 
provides a promising therapy for VL and a new therapeutic nanoplatform for obligate 
intracellular pathogens. 
INTRODUCTION  
The application of polymeric nanoparticles as delivery systems is becoming rather popular, as 
their use promise to overcome several problems associated with the administration of some 
drugs, vaccines and DNA [1]. The US FDA-approved poly(d,l-lactide-co-glycolide) (PLGA) 
polymer is widely used in delivery systems, and has gained particular significance due to its 
biocompatibility, biodegradability and capacity to maintain the drug in therapeutic levels for 
prolonged periods of time [2]. The polymer matrix protects the drug from degradation and the 
levels of its release from the nanoparticle can be manipulated by alterations in the formulation 
or in its surface. PLGA nanoparticles can exhibit a size similar to pathogens and be rapidly 
and efficiently phagocytized by antigen presenting cells (APCs), such as macrophages and 
dendritic cells (DCs), eliciting potent humoral and cellular immune response to the 
incorporated or adsorbed ligand [3]. It has been demonstrated that functionalized PLGA 
nanoparticles could elicit a potent cytotoxic T-lymphocyte immune response [4], which is 
perhaps related with the nanoparticle surface modification.  
Macrophages play a major role in connecting innate and adaptive immunity, which is 
important to favor the development of a protective immune response. These cells express a 
broad range of plasma membrane receptors that mediate their interactions with natural host 
components, as well as a range of microorganisms, which is crucial to its functions in 
homeostasis as well as host defense in innate and acquired immunity, autoimmunity, 
inflammation and immunopathology. C-type lectin receptors (CLRs) are highly conserved 
pattern recognition receptors with carbohydrate-recognition domains that bind sugars (e.g., 
mannose [M], fucose and N-acetylglucosamine) in a calcium-dependent manner, and can be 
found in the surface of many pathogens (bacteria, fungi and virus). In particular, mannose 
receptor (MR; CD206) was the first reported member of a family of four endocytic CLRs 
receptors, with a role in clearance of endogenous glycoproteins and in pathogen 
recognition/antigen presentation. Targeting pattern recognition receptors on macrophage 
offers the advantage of triggering specific signaling pathways to induce a tailored and robust 
immune response.  
Several studies have demonstrated the effectiveness of targeting CLRs to activate APCs, 
particularly DCs using mannoproteins from pathogens, by conjugation of glycans directly to 
the antigen or a carbohydrate to nanoparticles [5]. However, only a few studies have explored 
the use of carbohydrate-functionalized nanocarriers as a targeting drug delivery system 
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toward macrophages [6, 7]. Here, we describe functionalization of PLGA nanospheres with 
three conserved carbohydrate structures (M, mannan [MN] and mannosamine [Ms]) that have 
high affinity to MR on macrophages. We also investigate the mechanisms by which these 
functionalized PLGA nanospheres are internalized by and influence the activation of murine 
primary macrophages. The studies described herein demonstrate that MN-functionalized 
PLGA nanospheres induce a receptor-mediated activation of macrophages promoting a pro-
inflammatory environment that was further exploited as an immune-therapy approach toward 
visceral leishmaniasis (VL). 
MATERIALS AND METHODS 
Ethics statement. All procedures involving animals were approved by and performed in 
accordance with the Portuguese National Authority for Animal Health license  
(0042/000/000/2012) and the requirements/regulations lay down by the ethical review 
committee of IBMC. INEB Animal Ethics Committee. Animals were kept in ventilated cages 
and provided with food and water ad libitum and the 3Rs were respected. SA Costa Lima and 
A Cordeiro da Silva have an accreditation for animal research given from Portuguese National 
Authority for Animal Health (Ministerial Directive 1005/92). 
 
Reagents. Poly (vinyl alcohol) (87–89% hydrolyzed, MW 13,000–23,000 g/mol); D-(+)-M; MN, 
from Saccharomyces cerevisiae; D-Ms hydrochloride; N-hydroxy-succinimide; N-(3-
dimethylaminopropyl)-N’-ethyl-carbodiimide hydrochloride (DCC); ethylenediamine 
dihydrochloride (EDA); amphotericin B (AmB) from Streptomyces; and fluorescein 
isothiocyanate isomer I (FITC) were all purchased from Sigma-Aldrich (Sintra, Portugal). 
PLGA [70:30] was acquired from Poly-sciences, Inc. (Warrington, UK). The monoclonal 
antibodies were obtained from Biolegend (CA, USA). All other chemicals and reagents used in 
the study were reagent grade or higher. 
 
Preparation of fluorescein-loaded PLGA nanospheres. The FITC-loaded PLGA 
nanospheres were prepared in aseptic conditions. FITC was used as a model drug and its 
incorporation into PLGA nanospheres was obtained using the nanoprecipitation method as 
described [8]. All FITC-nanoformulations were tested for the presence of endotoxin using a kit 
(CellTox™; Promega, WI, USA) accordingly to the manufacturer instructions, and were shown 
to be endotoxin free. 
 
PLGA nanospheres surface functionalization. The functionalization with M was done by a 
carbodiimide chemical reaction. Briefly, 153 μg DCC, 459 μg N-hydroxysuccinimide and 160 
μg EDA was added to 10 mg of PLGA nanospheres, dispersed in 5 ml acidic phosphate 
buffered saline (PBS pH 5.0) and the mixture was then stirred at room temperature overnight. 
To the amine-terminated PLGA nanospheres, previously recovered by centrifugation, 20 mg 
of M was added and the mixture left under stirring overnight. The M functionalized 
nanospheres were then recovered by centrifugation. The functionalization with MN and Ms 
followed the above description of the carbodiimide chemical reaction without the presence of 
EDA [9]. 
 
Characterization of the nanospheres: size, zeta potential, surface morphology & 
carbohydrate content. Functionalized and nonfunctionalized nanospheres were 
characterized in terms of mean particle size, size distribution and zeta potential using a 
Zetasizer Nano ZS detector (Malvern Instruments, UK). The nanospheres were diluted with 
distilled water or culture medium complemented with 10% fetal bovine serum (FBS) to a final 
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concentration of 1 mg/ml and evaluated immediately or 24 h after incubation at 37°C. The 
morphology was observed by transmission electron microscopy (TEM, Jeol JEM-1400). The 
aqueous dispersion of nanospheres was placed on a carbon coated copper grids followed by 
negative staining with uranyl acetate and placed at the accelerating voltage of 60 kV. The 
level of incorporation of M and MN in PLGA nanospheres was determined by indirect 
quantification of the ligand present in the supernatants recovered from the washings of 
functionalized nanospheres, using phenol-sulfuric acid assay. In the same way, the ninhydrin 
assay was used to quantify the amount of Ms attached to the nanospheres. The total amount 
of sugar (μg/mg) was expressed in relation to polymer mass. 
 
Agglutination assay. To verify the activity of the carbohydrate moieties associated to the 
surface of PLGA nanospheres, an in vitro agglutination assay was performed. The time-
dependent increase in turbidity at 550 nm was monitored spectrophotometrically (Sinergy 2, 
BioTek; Bedfordshire, UK) for 90 min at 25°C. 
 
Determination of drug loading & encapsulation efficiency. The FITC loading was 
quantified by fluorimetry (Sinergy 2, BioTek; Bedfordshire, UK), after excitation at wavelength 
of 485 ± 10 nm the fluorescence emission was obtained at 528 ± 10 nm. Linear calibration 
curves were made in the range of 0.2–50.0 μg/ml and were used to quantify the 
nonincorporated compound. 
 
FITC in vitro release from the PLGA nanospheres. FITC release from the nonfunctionalized 
and functionalized PLGA nanospheres was evaluated over time in PBS buffer pH 7.4. A given 
amount of the nanoformulation correspondent to 0.5 mg of FITC was dispersed in 1.0 ml of 
PBS pH 7.4 and incubated at 37°C with shaking at 500 rpm. At known time intervals, 
nanospheres were separated from the supernatant through centrifugation. The nanospheres 
were then resuspended in fresh release medium and re-incubated in the same conditions. 
FITC present in the supernatant was quantified by fluorimetry in a microplate reader, as 
described above. 
 
Isolation & culture of murine bone marrow-derived macrophages. Macrophage primary 
cultures were generated as described previously [10]. For bone marrow-derived macrophages 
(BMM-φ) differentiation 5% L-cell conditioned medium was added at days 0 and 4, and at day 
7 half of the culture medium was renewed with 5% L-cell conditioned medium supplemented 
DMEM. 
 
Flow cytometric studies. Flow cytometry was done in a FACS Canto II (BD Biosciences, 
Madrid, Spain) and in all studies at least 10,000 events were analyzed, per sample.  
 
MR expression. The expression of MR was assessed by flow cytometry on different days of 
BMM-φ differentiation. At days 6, 7, 8 and 9, adherent cells were recovered, washed with cold 
FACS buffer (0.01% sodium azide, 2% FBS and 1% antibiotics mixture, 100 U/ml penicillin 
and 100 μg/ml streptomycin, in PBS pH 7.4) and stained with FITC-conjugated antimouse-
F4/80 and APC-conjugated antimouse-CD206 on ice during 30 min. 
 
Cellular uptake studies. The cellular uptake of FITC-loaded nanospheres was evaluated in 
BMM-φ at day 8 of differentiation upon incubation with nonfunctionalized and functionalized 
(0.5 mg/ml) PLGA nanospheres. After specific times, cells were washed with PBS pH 7.4 to 
remove noninternalized nanospheres and recovered in 0.2 ml of FACS buffer containing with 
0.11% Trypan Blue and incubated for 1 min in order to quench the FITC-fluorescent signal 
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coming from nanospheres adsorbed to the cell surface. Cells were examined in the flow 
cytometer and the auto-fluorescence of nontreated cells were used as control. 
 
Cell surface marker evaluation. For the analysis of the surface expression of co-stimulatory 
molecules, at day 8 of differentiation, BMM-φ were incubated with FITC-loaded nanospheres 
at a concentration of 1 mg/ml (in polymer). Nonstimulated and lipopolysaccharide (10 μg/ml) 
treated cells were used as negative and positive controls, respectively. After 20 h (37°C, 5% 
CO2), BMM-φ were washed thoroughly with cold FACS buffer and then recovered for surface 
co-stimulatory markers analysis. Antibodies used for assessment of activation included PE-
conjugated antimouse-CD40, BV-conjugated antimouse-CD86, PerCP/Cy5.5-conjugated 
antimouse-CD80, Alexa 647-conjugated anti-mouse-MHCII, APC-conjugated antimouse-
CD206 and PeCy7-conjugated anti-mouse-CD11b antibodies. Dead cells were excluded by 
staining with 7-A AD and the intensity of the expression of each cell surface marker was 
reported as mean fluorescence intensity of CD11b+/7-AAD- cells. 
 
Nanospheres internalization pathway. To study the pathways involved in the internalization 
of nanospheres, BMM-φ were preincubated with different inhibitors, listed in Supplementary 
Table 1 (see online at www.futuremedicine.com/doi/suppl/10.2217/nnm.14.116), for 30 min. 
After that time, cells were cultured with nonfunctionalized and functionalized (0.5 mg/ml) 
PLGA nanospheres. Cells with no inhibitor and with or without nanospheres were used as 
positive and negative controls, respectively. After 1 h of incubation, the cells were washed 
with PBS pH 7.4 and the internalization analyzed by flow cytometry upon 1 min incubation 
with Trypan Blue. Dead cells were excluded by staining with 7-AAD. The results were reported 
as mean fluorescence intensity of cells with inhibitor, which were normalized relative to 
positive control. 
 
Secreted cytokine assay. After 20 h of stimulation with FITC-loaded non-functionalized or 
functionalized PLGA nanospheres, cell-free supernatants were collected and assayed for IL-4, 
IL-6, IL-12p40 and TNF-α by an ELISA assay accordingly to the manufacturer’s instructions  
(Biolegend). 
 
Fluorescence microscopy: Nanospheres internalization pathway. The internalization of 
FITC-loaded nanospheres was also evaluated by fluorescence microscopy (Leica DMI6000B). 
BMM-φ were cultured onto 12-mm diameter coverslips on a 24-well plate, and at day 8 of 
differentiation were treated with nonfunctionalized and functionalized (0.25 mg/ml) PLGA 
nanospheres. After specific times, cells were washed with PBS pH 7.4, to remove 
noninternalized nanospheres, fixed and then the coverslips were mounted onto slides using 
DAPI-Vectashield (Vector Laboratories, Inc., CA, USA). The images were overlaid with 
imaging software ImageJ to visualize co-localization. 
 
Fluorescence microscopy: Nanospheres intracellular trafficking. To study the 
intracellular trafficking of nanospheres, BMM-φ were cultured, as described previously. After 2 
h the cells were washed and stained with Early Endosomes-RFP or LysoTracker Red for 15 
and 30 min, respectively. Cells were then washed with PBS pH 7.4, fixed and the coverslips 
were mounted onto slides using DAPI-Vectashield (Vector Laboratories, Inc., CA, USA). Cells 
were observed using a Leica DMI6000B microscope (Leica, Wetzlar, Germany). The images 
were overlaid with imaging software ImageJ to visualize co-localization. 
 
Parasites & cell culture. A cloned line of Leishmania infantum (L. infantum, 
MHOM/MA/67/ITMAP-263) promastigotes, stably expressing the luciferase gene (LUC) and L. 
infantum axenic amastigotes were derived from LUC-expressing promastigotes and were 
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grown and used to infect macrophages as already reported [8]. The human leukemia 
monocyte THP1 cell line was grown and differentiated into macrophages, as described 
previously [8]. 
 
Production of AmB-loaded MN-functionalized PLGA nanospheres. The preparation of 
AmB-loaded PLGA nanospheres was based on the nanoprecipitation method. Briefly, 25 mg 
of polymer and 0.5 mg of AmB (drug loading [w/w] of 2%) was dissolved in 4 ml of acetone 
and 0.2 ml of DMSO, respectively. This organic phase was adjusted to pH 4, using HCl, in 
order to promote the AmB solubilization and then added to an aqueous solution of 0.5% (w/v) 
of Poly (vinyl alcohol), under magnetic stirring. After solvent evaporation nanospheres were 
recovered by centrifugation. The functionalization with MN was achieved by the carbodiimide 
chemical reaction described above. Nanospheres were sterilized by exposure to UV light 
during 20 min and stored at 4°C until further use. AmB loading on the functionalized and 
nonfunctionalized PLGA nanospheres was determined directly by addition of DMSO followed 
by AmB quantification at 392 nm by spectrophotometry (Shimadzu ® UV-2401 PC, EVISA, 
Duisburg, Germany). 
 
In vitro cytotoxicity on macrophages & intracellular L. infantum amastigotes. The in vitro 
toxicity of free AmB and respective loaded nanoformulations toward human THP1 
differentiated macrophages and murine BMM-φ was evaluated using the MTT assay, as 
previously described [8]. The amount of free AmB was equivalent to the AmB amounts 
present on the nanospheres. The activity of free and loaded AmB nanoformulations against 
LUC-expressing amastigotes on human THP1 differentiated macrophages and murine BMM-φ 
was evaluated using a luciferase assay system (Promega, WI, USA) [8]. 
 
In vivo studies: Animals, infection & treatment. Six-week-old male Balb/c mice were 
purchased from Charles River (Barcelona, Spain). Animals were housed under specific 
pathogen-free conditions for acclimatization, at the animal resource facilities of IBMC, 1 week 
before the experiments. For infection of Balb/c mice, 10
8 
stationary phase L. infantum 
promastigotes were injected intraperitoneally. Infected mice (6 mice/group) received a single-
dose treatment of Fungizone ® (Life Technologies, ThermoFisher Scientific, Inc., MA, USA) (1 
mg/kg) or empty MN-functionalized PLGA nanospheres (1 mg/kg) or AmB-loaded MN-
functionalized PLGA (1 mg/kg of AmB on MN-PLGA nanospheres). After 14 days of infection, 
mice (3-4 mice/group) were treated by intraperitoneal injection and given the treatment 
described above. One week after treatment administration, mice were euthanized and spleen 
and liver were aseptically recovered for parasite quantification by serial dilution assay. The 
total organ parasite burden was calculated using the weight of the respective organs.  
 
Cytokines production by ELISA & quantification of total nitrites. The supernatant of 96-h 
culture of splenocytes (2 × 10
5
/well) recovered from the differently treated animal groups was 
used for quantification of cytokines and nitric oxide (NO). Secreted cytokines were quantified 
in the supernatants after stimulation or not with concanavalin A (ConA; 6 μg/ml) or soluble 
Leishmania antigens (SLAs; 25 μg/ml) by ELISA. IL-10, IFN-γ, TNF-α and IL-12p40 were 
measured in all infected untreated and treated mice. Samples were assayed in triplicate, and 
data were expressed as the mean ± standard deviation (SD). The NO content was quantified 
in the supernatants after stimulation with SLAs (25 μg/ml) using the Griess method. 
 
Data analysis. Data were presented as the mean ± SD and all experiments were 
independently repeated at least three-times. p-values < 0.05 (two sided) were considered as 
statistically significant. For the in vivo studies the statistical significance was assessed using 
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one-way ANOVA followed by Dunnett’s post-test calculated by GraphPad Prism 6 software 
(La Jolla, CA, USA). 
 
RESULTS & DISCUSSION 
Physicochemical characterization of nanospheres. Size and surface charge are the most 
important characteristics of nanocarriers since they are the major determinants of the cellular 
uptake mechanism and intracellular fate, defining the nanocarriers in vivo performance [11]. 
Table 1 summarizes the main physicochemical properties of FITC-loaded nanospheres used 
in this study. Nonfunctionalized PLGA nanospheres had an average size of 179.9 ± 5.8 nm, 
and loading with FITC led to a significant increase (p < 0.001) to 200.1 ± 6.0 nm. 
Functionalization of empty PLGA nanospheres with carbohydrates (M or MN) increase the 
nanospheres size (194.4 ± 8.1 [p < 0.001], 191.2 ± 2.7 [p < 0.01], respectively). When FITC 
was incorporated on the carbohydrate-functionalized PLGA nanospheres, we observed a 
significant increase (p < 0.001 and p < 0.01 for M and MN, respectively) on the average size 
to values of 211.4 ± 9.7 and 202.2 < 2.4 nm. For the Ms functionalized empty or FITC-loaded 
PLGA nanospheres the size was identical to nonfunctionalized empty PLGA nanospheres. All 
prepared nanoformulations exhibited size (179.9 ± 5.8 to 211.4 ± 9.7 nm) within the range 
suitable for uptake by macrophages [12]. To evaluate the influence of protein present in cell 
culture conditions the nanoformulations were incubated for 24 h at 37°C in the presence of 
10% FBS and no statistically significant changes were observed when compared with the 
formulations at buffered conditions.  
The polydispersity index (PDI) characterizes the nanocarriers in terms of size homogeneity by 
a value of the relative variance of sizes within the population. The nonfunctionalized and 
functionalized PLGA nanospheres obtained were mono-disperse, with PDI values always 
below 0.1 (Table 1), suggesting a relatively uniform size. 
The nonfunctionalized nanospheres exhibited a ζ-potential of -16.5 ± 0.5 mV, which was 
neither affected with the incorporation of FITC, nor with the carbohydrate functionalization (p = 
0.1154), consistent with the presence of carboxyl groups that remained free. Under normal pH 
conditions FITC confers partial negative charges. Indeed, the incorporation of FITC on the 
carbohydrate-functionalized nanospheres lead to a modest (p < 0.01) increase on the net 
negative surface charge of the nanocarriers, except for MN-functionalization. In this case, no 
differences were found on the surface charge of the nanocarriers, which could be explained 
by masking of the negatively charged carboxyl end groups following esterification with MN [9]. 
The surface charge can influence particle stability, and is widely described that high values, 
either positive or negative, tend to stabilize the nanocarriers to a greater extent, as is the case 
of our functionalized FITC-loaded PLGA nanospheres (∼ -2 4 mV ). 
The carbohydrates moieties functionalized nanospheres were confirmed using Fourier 
transform infrared spectroscopy, to quantitatively determine successful linker and 
carbohydrate conjugation to the nanospheres surface. The Fourier transform infrared spectra 
obtained for carbohydrate functionalized PLGA nanospheres present a prominent peak at 
1630 cm
-1
, representing the covalent binding that is not observed in the spectrum of 
nonfunctionalized nanospheres (Supplementary Figure 1). The total amount of carbohydrate 
attached to the nanospheres surface was quantified by phenol-sulfuric acid (M and MN) or the 
ninhydrin assay (Ms) and was normalized to the total mass of nanospheres. The amount of 
carbohydrate conjugated to the PLGA nanospheres were 761.4 ± 13.1, 929.1 ± 34.8 and 
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822.0 ± 18.5 μg of M, MN and Ms, respectively, per mg of nanospheres. When PLGA 
nanospheres had FITC incorporated, a decrease in the amount of carbohydrate was found to 
levels of 546.4 ± 7.3, 761.7 ± 43.7 and 743.7 ± 22.6 μg of M, MN and Ms, respectively, per 
milligram of nanospheres. The carbohydrate functionalization is conducted under acidic 
conditions that may contribute to FITC protonation, weakening the carbohydrate attachment to 
the nanospheres surface.  
The morphological analysis by TEM confirmed the presence of spherical particles with a size 
similar to that obtained by dynamic light scattering (Figure 1A–D & Table 1). To study the 
presence and orientation of carbohydrates in the surface of PLGA nanospheres (Figure 1E). 
FITC loading was calculated to be 217.9 ± 20.7 μg FITC per mg of nanospheres with an 
encapsulation efficiency close to 56%. The integrity and in vitro release of FITC after its 
incorporation in the PLGA nanospheres was evaluated, as FITC is not covalently bound to the 
polymer. The fluorescence spectrum was similar to free FITC (data not shown) and the in vitro 
release assay revealed that only around 3% of total incorporated FITC is released during 6 
days at 37°C (Figure 1F). 
The effect of surface functionalization on the uptake of PLGA nanospheres by BMM-φ. 
The expression of MR on the primary culture of BMM-φ was studied by flow cytometry. The 
data revealed that MR expression is time-dependent (Figure 2A). At day 8 of BMM-φ 
differentiation was observed the maximum expression of MR (77.9% of the whole cultured 
cells) in the F4/80+ population. In the following studies BMM-φ with 8 days of differentiation 
was used.  
The cellular uptake of nonfunctionalized and functionalized PLGA nanospheres was followed 
by flow cytometry. According to the in vitro release data (Figure 1F) minimum release (<5%) of 
FITC occurs, indicating that for all fluorescence in PLGA nanospheres observed is due to their 
internalization. The internalization of the nonfunctionalized and functionalized PLGA 
nanospheres was time dependent (Figure 2B). As early as 30-min postincubation, 
nanospheres were found within the cells CD11b+/FITC+ and it appears that a saturation limit 
was reached for nonfunctionalized nanospheres at about 2 h (Figure 2B & C). Evidence of 
saturation of nanocarriers uptake has been previously documented in the literature for other 
cell types [13]. The PLGA nanospheres surface functionalization led to an increase (M, p < 
0.01); MN and Ms (p < 0.001) in the level of uptake of the nanospheres by the BMM-φ when 
compared with the nonfunctionalized nanospheres, after 24 h. There are no significant 
differences in the uptake between the three carbohydrate-functionalized PLGA nanospheres. 
In delivery systems, cellular uptake profile will reflect the delivery efficiency and the 
bioavailability of the nanocarriers.  
The fluorescence microscopy images confirmed the internalization of the nonfunctionalized 
and functionalized PLGA nanospheres by BMM-φ after 24 h of incubation, as shown by the 
presence of green dots within the cytoplasm (Figure 2C–E).  
Lysosomal fate of the PLGA nanospheres on BMM-φ. In general, the intracellular outcome 
of nanocarriers is strongly affected by the route of entry in the cell. Remarkably, depending on 
the physicochemical characteristics, the internalization pathway as well as the intracellular 
fate of nanocarriers, is a key issue for the drug to be efficiently delivered. The release of the 
drug into the enzymatic environment of the lysosomes or directly in the cell cytoplasm will, 
indeed, have impact on the pharmacological activity. To determine whether the uptake 
mechanism of PLGA nanospheres entry, into 8-day differentiated BMM-φ was mediated by 
endocytosis, the cells were incubated with nonfunctionalized and functionalized PLGA 
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nanospheres and maintained at 4°C, since endocytosis as an energy dependent process, is 
blocked at low temperatures. We observed that the uptake of all PLGA nanospheres was 
significantly decreased at 4°C (Figure 3A), suggesting that their uptake is mediated by 
endocytosis. Several endocytic pathways for macromolecules are identified so far: clathrin-
mediated endocytosis, caveolae-mediated endocytosis, macropinocytosis and clathrin- and 
caveolae-independent endocytosis [11]. In order to identify the uptake mechanisms involved 
in the cellular entry of functionalized PLGA nanospheres, we employed several specific 
endocytic inhibitors (Supplementary Table 1). When BMM-φ were preincubated with 
chlorpromazine, an inhibitor of clathrin-mediated endocytosis, and then with nonfunctionalized 
and functionalized PLGA nanospheres, the uptake was reduced by 20–40%, respectively, 
compared with nontreated cells (Figure 3A). Among the different carbohydrates, the inhibition 
was more pronounced with MN-functionalized nanospheres (∼40%). Similarly, when cells 
were pretreated with hypertonic conditions (0.45 M sucrose), also an inhibitor of clathrin-
mediated endocytosis, uptake of all PLGA nanospheres by the BMM-φ was reduced by 
approximately 40%, in relation to the nontreated cells. Sucrose leads to a more pronounced 
effect on the uptake of nonfunctionalized nanospheres, which suggests that the mechanism of 
action the chlatrin-mediated endocytosis inhibitors influence the overall effect of the 
internalization. Indeed, it has been described that hyperosmotic sucrose acts by preventing 
clathrin and adaptors from interacting; while cationic amphiphilic drugs as chlorpromazine 
cause a decrease in coated pits on the cell surface and clathrin lattices assembly on 
endosomal membranes. In our work, BMM-φ treatment with hyperosmotic sucrose leads to 
approximately 40% inhibition of nonfunctionalized PLGA nanosphere internalization (Figure 
3A, 0.62 ± 0.11), indicating that the few coated pits remaining functional after hyperosmotic 
sucrose are sufficient to internalize 60% of the nanospheres. Chlorpromazine treatment of 
BMM resulted in approximately 20% inhibition of nonfunctionalized PLGA nanosphere 
internalization (Figure 3A, 0.81 ± 0.05). The preincubation of the cells with filipin III, a selective 
inhibitor of caveolae formation, only influenced the uptake of MN-functionalized PLGA 
nanospheres by the BMM-φ with approximately 20% inhibition, when compared with 
nontreated cells (Figure 3B). When cells were preincubated with cytochalasin D, a 
macropinocytosis inhibitor, and then with each type of PLGA nanospheres under study, no 
inhibitory effect was observed in the uptake, as compared with the nontreated cells (Figure 
3B). Taken together, these studies suggest that the internalization of nonfunctionalized and 
functionalized PLGA nanospheres occurs, mainly, through clathrin-mediated endocytosis. In 
particular, MN-functionalization lead to more than one cellular uptake mechanism, clathrin- 
and caveolae-mediated endocytosis are likely to take place in the translocation processes of 
these nanoparticles across the lipid bilayer of the cell plasma membranes. This outcome can 
partly be explained by nanospheres size, which is a major parameter defining nanocarriers 
endocytosis process and is well known that the diameter of clathrin-coated vesicles ranges 
between 100 and 200 nm while caveosomes have a general diameter of approximately 60–
100 nm [11]. It should be noticed that the discrepancy between the typical endosome sizes 
described in literature and the actual size of nanocarriers can be explained on fundamental 
biological processes, involving pinocytosis, thus imposing less mechanical constraints on the 
vesicle formation.  
Certain internalization pathways, such as clathrin-mediated endocytosis, may lead to a 
complete degradation of the nanocarriers at the later lysosomal stage. To identify the 
intracellular trafficking of the nonfunctionalized and functionalized PLGA nanospheres, we 
performed co-localization assays with EEA1 and LysoTracker, as known markers for early 
endosomes and lysosomes, respectively. As shown in Figure 3D–G, co-localization (yellow 
color) of FITC-loaded PLGA nanospheres with LysoTracker-red demonstrated that the 
particles are primarily transported to lysosomes following endocytosis by BMM-φ. Few co-
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localization signals were observed in EEA1 (data not shown), which indicates that all types of 
PLGA nanospheres are not typically localized within early endosomes. Lysosomotropic agents 
were used to clarify the involvement of the endosomal/lysosomal compartments in the 
internalization of the nanospheres by BMM-φ. When BMM-φ were pretreated with ammonium 
chloride and then incubated with nonfunctionalized and functionalized FITC-loaded PLGA 
nanospheres a significant inhibition in the uptake was observed (Figure 3C). The 
carbohydrate functionalization of the PLGA nanospheres, in particularly, MN- and Ms-, is more 
dependent of the lysosome compartment when compared with nonfunctionalized 
nanospheres. Taken together these data, it is proposed that all the PLGA nanospheres used 
in this study undergo endosomal internalization, trafficking to the lysosome. Degradation of 
nanocarries in lysosomes plays an important role in drug delivery to intracellular pathogens 
[14]. Within lysosomes the nanocarriers are degraded into smaller fragments and the 
incorporated drug/agent can be released through surface or bulk erosion of the degradable 
polymers, promoting a sustained drug release from the lysosomal compartments, which could 
be highly advantageous for drug delivery applications. Particle surface charge determines the 
nanocarriers trafficking in cells and it was described that anionic but not cationic nanocarriers 
transited through the lysosomal pathway [15], which is consistent with our findings.  
MN-functionalized PLGA nanospheres enhanced BMM-φ expression of MHC II, & co-
stimulatory molecules. Contrary to DCs, macrophages do not have a constitutive expression 
of migratory and co-stimulatory molecules, their expression at macrophages surface occurs 
only upon activation [16]. Thus, we assess by flow cytometry the expression of these specific 
surface markers to determine the influence of nonfunctionalized and functionalized PLGA 
nanospheres in the activation status of BMM-φ. Here, we observe increased expression of 
surface markers associated with antigen processing and presentation (MHCII) and T-cell co-
stimulation (CD86, CD80 and CD40) in BMM-φ upon 20 h of incubation with functionalized 
PLGA nanospheres, as compared with nonfunctionalized nanospheres (Figure 4A–D). When 
BMM-φ were cultured with functionalized PLGA nanospheres we also observed an increase 
on the surface expression of the MR in comparison to nonfunctionalized nanospheres (Figure 
4F). This evidence indicates a positive self-regulation of the CLR, upon MR recognition, by the 
carbohydrate, which is supported by the fact that CLRs undergo internalization and recycling 
between the plasma membrane and the endosomal compartments [5]. Another interesting 
observation is that the MN-functionalization of PLGA nanospheres induced higher expression 
of MHCII and co-stimulatory molecules as compared with M-functionalized nanospheres. 
Previously, it has been reported that soluble carbohydrate and nonfunctionalized nanospheres 
plus soluble carbohydrates did not change cell surface marker expression, endorsing the 
contribution of the covalent bond of the carbohydrate to the nanospheres surface [15]. Several 
other types of carbohydrates (lactose, galactose) have been used to functionalize the surface 
of nanocarriers targeting MR on macrophages, with concomitant cell activation [5]. 
Although the expression of MHCII, CD40, CD80 and CD86 in macrophages is essential, it is 
not sufficient to induce T-cell activation. Thus, it is crucial that the activation of macrophages 
leads to the production of different cytokines, in order to favor the development of a more 
effective immune response. In particular, the production of pro-inflammatory cytokines is 
essential for the activation of macrophages, to stimulate their antimicrobial properties and to 
initiate adaptive immune responses. The incubation of 8-day differentiated BMM-φ for 20 h 
with either nonfunctionalized or functionalized PLGA nanospheres loaded with FITC increased 
the secretion of pro-inflammatory cytokines IL-6, IL12p40 and TNF-α, in comparison to the 
nonstimulated controls (Figure 4F–H). The greatest amounts of IL-6 and TNF-α were 
produced by BMM-φ stimulated with MN-functionalized PLGA nanospheres (Figure 4F & G). 
These results are in agreement with studies demonstrating that the targeting of MR in 
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macrophages resulted in the production of pro-inflammatory cytokines [5]. Interestingly, the 
functionalization with the different carbohydrates increased the secretion of IL-4, a Th2 
cytokine, by BMM-φ when compared with nonfunctionalized nanospheres (Figure 4I). Levels 
of IFN-γ for M, MN and Ms-PLGA nanospheres were 1760 ± 72, 2100 ± 54 and 2240 ± 41 
pg/ml, respectively, which supports the immune-modulatory role of the nanospheres toward a 
Th1 response. The presence of IL-4 in extravascular tissues promotes MR expression on 
macrophages [17]. In our results, the carbohydrate functionalization leads to an increase of 
MR expression on BMM-φ which can be associated to the secretion of IL-4 and the 
continuous uptake of the functionalized PLGA nanospheres through clathrin-mediated 
endocytosis. Together, these observations indicate that carbohydrate functionalization of 
PLGA nanospheres enhanced BMM-φ activation. In particular, MN- or Ms-functionalization 
was sufficient to activate BMM-φ, suggesting that surface charge contributes to the activation. 
Indeed, carbohydrate functionalization of polyanhydride nanoparticles was described to 
enhance alveolar macrophage activation as compared with nonfunctionalized particles, 
accordingly to the nanoparticle surface charge [5]. 
To this point, it was demonstrated that carbohydrate functionalization of PLGA nanospheres, 
particularly with MN, improve their immunotherapeutic effect on BMM-φ, through the induction 
of a more efficient activation of macrophages, which could lead to the development of a robust 
immune response. These observations lead us to pursue a biological application that could 
benefit from immune-modulatory properties of the MN-functionalized PLGA nanospheres. The 
intracellular parasite Leishmania spp. has the ability to survive and multiply within DCs and 
macrophages, and for that is consider an ideal model to study obligate intracellular microbes 
(Mycobacterium tuberculosis, Listeria monocytogenes, Salmonella typhimurium, Toxoplasma 
gondii, Trypanosoma cruzi and HIV). An immune-modulatory nanocarrier, such as MN-
functionalized PLGA nanospheres, that target APCs, can be an attractive approach for the 
direct targeting of chemotherapeutics to VL infected cells.  
Production of AmB-loaded MN-functionalized PLGA nanospheres. Previous reports from 
our laboratory have described the ability of nonfunctionalized PLGA nanospheres to improve 
in vivo efficacy of AmB on a VL experimental model [10]. In the present work, we sought to 
extend our findings by asking if functionalization with specific carbohydrates (MN was the 
selected one) provides additional immune-stimulatory ability to the PLGA nanospheres and 
thus improving AmB efficacy.  
We have employed the nanoprecipitation technique to incorporate AmB on MN-functionalized 
PLGA nanospheres. The physicochemical properties of the nanospheres were studied ( Table 
2 ). The incorporation of AmB did not affect the physicochemical properties of the MN-
functionalized PLGA nanospheres and was possible to achieve about 57.5 ± 4.3% 
encapsulation efficiency with an initial drug loading of 2%, corresponding to 5.8 ± 0.4 μg AmB 
per mg of PLGA. Others have reported encapsulation values above 50% for AmB in PLGA 
nanospheres with higher initial drug loading values (10–30%) [18]. AmB is a highly 
hydrophobic drug contributing to the successful application of the nanoprecipitation technique, 
as indicated by the encapsulation efficiency value. We can also consider that the possible 
electrostatic interaction between capped carboxyl groups of PLGA and the positively charged 
primary amine group of AmB may contribute to the incorporation of AmB on the nanospheres. 
No morphological differences were observed by TEM with the incorporation of AmB on the 
MN-functionalized PLGA nanospheres (Supplementary Figure 2). 
In vitro & in vivo efficacy of AmB-loaded MN-functionalized PLGA nanospheres. The in 
vitro cytotoxicity of AmB (free form and loaded in MN-PLGA nanospheres) was evaluated in 
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human THP1 differentiated macrophages and murine BMM-φ (Supplementary Figure 3). Free 
AmB is able to inhibit 50% of the cell growth at 19.8 ± 3.6 and 21.8 ± 2.8 μg/ml for THP1 and 
BMM-φ, respectively. When loaded on MN-functionalized PLGA nanospheres, a significant 
reduction of AmB toxicity was observed, both on human and murine macrophages with IC50 
values higher than 50 μg/ml. In the mammalian host, the parasite L. infantum resides inside a 
phagolysosome. Both free AmB and its nanoformulation demonstrated to be efficient in 
reducing the intracellular growth of L. infantum amastigotes on THP1 and BMM-φ (Table 3). 
Moreover the AmB-loaded MN-functionalized PLGA nanospheres were able to retain free 
AmB efficacy and to improve it by 70- and 94-fold in intracellular L. infantum amastigotes in 
THP1 differentiated macrophages and BMM-φ, respectively. No toxicity was observed 72 h 
after treatment with up to 2 mg/ml in polymer toward the mammalian cells and intracellular L. 
infantum amastigotes. Together these observations indicate that the incorporation of AmB on 
MN-functionalized PLGA nanospheres reduced its drug cellular toxicity on macrophages and 
retained and improved its antiparasitic activity, which, and most probably, allow application of 
higher doses, improving AmB efficacy and safety. 
Next, we assessed the efficacy of AmB-loaded MN-functionalized PLGA nanospheres in a VL 
susceptible murine model. After acute infection (14 days after the infection), single dose at 1 
mg/kg in AmB was administered via intraperitoneal (ip.) injection, draining the nanocarriers or 
larger compounds (MW >20 kDa) through the lymphatic ducts. Here, we thus expected that 
the nanocarriers reach the systemic circulation via the lymphatics relatively quickly, due to 
their small size. One week upon the administration, we have observed that the group 
receiving AmB-loaded MN-functionalized PLGA nanospheres had significant reduction (p < 
0.001) on the parasite load on both splenic and liver tissues (Figure 5A & B), when compared 
with intraperitoneal AmB (Fungizone) treated and control, empty MN-functionalized PLGA 
nanospheres groups. Indeed, a single dose of AmB-loaded MN-functionalized PLGA 
nanospheres promoted a reduction of 99.1 ± 1.3% and 99.5 ± 1.1%, in the spleen and liver, 
respectively; as compared with the vehicle control. Specifically, in the spleen the untreated 
group had a log of 8.86 ± 0.45 parasites/g while the functionalized-treated group had 5.37 ± 
0.20 parasites/g; the data were similar in the liver: 8.43 ± 0.32 and 4.78 ± 0.15 parasites/g, 
respectively. Nonfunctionalized PLGA nanospheres loaded with AmB were also able to lower 
both splenic and hepatic parasites by 2.5- and 2-logs, respectively (unpublished results, 
Supplementary Figure 4). The new AmB nanoformulations has demonstrated efficacy in short-
term treatment without achieving cure. A different treatment scheme associated with a longer 
term treatment could lead to control of the infection and eventually cure. It is relevant to note 
that the MN-functionalized PLGA nanospheres loaded with AmB combining AmB therapeutic 
efficacy with macrophage activation was more efficient than Fungizone, currently used in the 
VL treatment. 
As IFN-γ and IL-10 are described to be essential cytokines governing the fate of the infection 
in VL, we quantified their secretion by splenocytes recovered from all treatment groups. 
Indeed, AmB-loaded MN functionalized PLGA nanospheres treated mice exhibited IFN-γ 
levels significantly higher, in comparison with Fungizone or empty MN-functionalized PLGA 
nanospheres treated infected mice (Figure 5C). The IFN-γ/IL-10 ratio was higher in 
functionalized-nanoparticles treated mice than in untreated, AmB- or empty nanospheres 
treated animals. To unravel the status of the IFN-γ/IL-10 ratio in functionalized-nanoparticles 
treated mice, levels of TNF-α and nitric oxide were also quantified. The AmB-loaded MN-
functionalized PLGA nanospheres treated mice had a 2.3-fold increase in TNF-α in 
comparison with the infected untreated mice, while Fungizone treated mice showed a 1.8-fold, 
when compared with infected untreated mice (Figure 5E). This results in an increase of NO 
production (Figure 5F). The AmB-loaded MN-functionalized PLGA nanospheres treated mice 
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had a fourfold increase in NO production, in comparison with the infected untreated mice, 
while Fungizone treated mice showed a threefold increase, when compared with infected 
untreated mice (Figure 5E). In VL, macrophages are both the host cell for Leishmania 
replication and the effector cell for parasite killing. When macrophages become infected are 
unable to trigger a pro-inflammatory response, but the delivery of AmB to these macrophages 
will enable parasite killing by apoptosis. To be successful, this process also needs to be 
supplemented with TNF-α, iNOS should be induced, IL10 has to be neutralized leading to the 
production of IFN-γ [19]. Indeed, our results show that AmB-loaded MN-functionalized PLGA 
nanospheres treatment of experimental VL led to the rapid killing of parasites in macrophages, 
and to increased IFN-γ, TNF-α and NO levels. 
Shimizu et al. have demonstrated that the i.p. administration of oligomannose-coated 
liposome-entrapped SLAs strongly induces an antigen-specific Th1 immune response in 
BALB/c mice [20]. In our study, the MN-functionalization of the PLGA nanospheres increased 
MHCII expression triggering a Th1-like pathogen specific immune response, and together with 
the AmB loading, these nanocarriers not only reduced, in vitro, the effective drug dose and 
toxicity, it also activated the macrophages to commit to a Th1 response leading to an effective 
adaptive immune response against this intracellular pathogen. 
CONCLUSION 
In conclusion, we demonstrated that carbohydrate functionalization of PLGA nanospheres 
leads to immune-modulatory properties on macrophages, eliciting a pro-inflammatory 
response, upon clathrin-mediated endocytosis. Efficient uptake by macrophages led to 
lysosome accumulation that acts as a perfect reservoir for continuous exposure of an 
intracellular pathogen to a delivered drug. As a proof of concept, the AmB-loaded on MN-
functionalized PLGA nanospheres confirmed superior in vivo efficacy, in comparison with 
Fungizone, against VL infection. A single injection and a 1-week course of treatment were 
sufficient to achieve significant decrease on the visceral organs parasite load. The 
pharmacologically activity of AmB was improved by MN-functionalized PLGA nanospheres, 
that triggered host immune responses to parasite killing resulting in a promising therapy for 
VL. The developed MN-functionalized nanocarriers could represent a huge advantage in the 
treatment strategy of obligate intracellular pathogens, which continue to have a major negative 
impact on public health. 
FUTURE PERSPECTIVE 
Targeting CLRs by surface functionalization of polymeric nanospheres represents a promising 
approach to modulate the immune system. Carbohydrates commonly found on the surface of 
pathogens, such as MN, can significantly enhance the interaction of polymeric nanospheres 
and macrophages by further upregulating surface expression markers, T-cell co-stimulatory 
molecules and the secretion of proinflammatory cytokines. For intracellular pathogens, 
delivery of an active agent associated with a controlled proinflammatory immune response 
may be highly beneficial. With the inherent advantage described in this work of enhanced 
therapeutic efficacy, the proposed MN-functionalized polymeric nanospheres represent an 
interesting nanoplatform for intracellular pathogens. Nevertheless, deeper understanding on 
how these carbohydrate-functionalized nanospheres interact with the immune cells will be 
highly valuable. 
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TABLES & FIGURES 
 
  
Table 1. Physicochemical properties of nonfunctionalized and functionalized poly(d,l-lactide-co-glycolide) nanospheres empty or loaded with FITC. 
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Table 2. Physicochemical properties of empty and amphotericin B-loaded mannan-functionalized poly(d,l-lactide-co-glycolide) nanospheres. 
 
 
Table 3. Biological effect of amphotericin B in free drug form and loaded on mannan-functionalized poly(d,l-lactide-co-glycolide) nanospheres on 
Leishmania infantum intracellular amastigotes. 
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Figure 1. FITC-loaded poly(d,l-lactide-co-glycolide) nanospheres characterization. Morphology of nonfunctionalized 
(A) and functionalized M (B), MN (C), Ms (D) PLGA nanospheres at 80,000× magnifications; bars represent 0.2 μm. 
(E) Agglutination assay of M-, MN- and Ms- functionalized PLGA nanospheres with ConA. (F) FITC in vitro release 
kinetics from nonfunctionalized (PLGA FITC) and functionalized (M, MN, Ms) PLGA nanospheres. Mean ± SDs (n 
=3). FITC: Fluorescein isothiocyanate isomer I; M: Mannose; MN: Mannan; Ms: Mannosamine; PLGA: Poly(d,l-
lactide-co-glycolide); SD: Standard deviation. 
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Figure 2. Mannose receptor expression during murine bone marrow-derived macrophage differentiation and cellular 
uptake of FITC-loaded nonfunctionalized and functionalized poly(d,l-lactide-co-glycolide) nanospheres. (A) 
Histograms representing MR expression at days 6, 7, 8 and 9 of differentiation. The solid gray and black lines 
represent F4/80+ unstained cells and F4/80+/MR+ cells, respectively. (B) Uptake of FITC-loaded nanospheres by 
bone marrow-derived macrophages with 8 days of differentiation at different incubation times, evaluated by flow 
cytometry. Bars represent mean ± SD (n = 3). Fluorescence microscopy images of the internalization of FITC-loaded 
nonfunctionalized (C) and M (D), MN (E), Ms (F) functionalized nanospheres by bone marrow-derived macrophages 
after 24 h of incubation. M: Mannose; MFI: Mean fluorescence intensity; MN: Mannan; MR: Mannose receptor; Ms: 
Mannosamine; PLGA: Poly(d,l-lactic-co-glycolic acid); SD: Standard deviation. 
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Figure 3. Mechanism of intracellular internalization of functionalized poly(d,l-lactide-co-glycolide) nanospheres. 
Effect of different inhibitors on the internalization of nonfunctionalized and functionalized PLGA nanospheres, (A) 
Inhibitors of clathrin-mediate endocytosis (4°C; chlorpromazine and sucrose); (B) Filipin inhibits caveolae-mediated 
endocytosis and Cytochalasin D inhibits macropinocytosis. (C) Effect of NH4Cl on the internalization of 
nonfunctionalized and functionalized PLGA nanospheres. The results were normalized against the cells with no 
inhibitor, mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 compared with cells with no inhibitor. Co-localization 
(yellow color) with lysosome of (D) nonfunctionalized and functionalized ([E] mannose; [F] mannan; [G] 
mannosamine), on bone marrow-derived macrophages. Nucleus is stained with DAPI (blue), lysossome with 
LysoTracker (red) and nanospheres shown in green fluorescence. Representative images are shown with a 
magnification of 1000×. M: Mannose; MFI: Mean fluorescence intensity; MN: Mannan; MR: Mannose receptor; Ms: 
Mannosamine; NF: Nonfunctionalized; NP: Nanoparticle; PLGA: Poly(d,l-lactide-co-glycolide); SD: Standard 
deviation. 
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Figure 4. Immune-modulation of bone marrow-derived macrophages by functionalized poly(d,l-lactide-co-glycolide) 
nanospheres. Surface expression of (A) CD40, (B) CD80, (C) CD86, (D) MHCII and (E) MR in BMM-φ after 20 h of 
incubation. Profile of secreted cytokines induced in BMM-φ by functionalized poly(d,l-lactide-co-glycolide) 
nanospheres (F) TNF-α, (G) IL- 6, (H) IL-12p40 and (I) IL- 4. NS and lipopolysaccharide-stimulated cells were used 
as negative and positive control, respectively. BMM-φ were cultured with NF and functionalized (mannose, mannan 
and mannosamine) poly(d,l-lactide-co-glycolide) nanospheres. Results are expressed as the mean ± SD of three 
independent experiments performed in duplicate. * p < 0.05, ** p < 0.01 and *** p < 0.001 compared with 
nonfunctionalized. BMM-φ: Bone marrow-derived macrophages; LPS: Lipopolysaccharide; MFI: Mean fluorescence 
intensity; NF: Nonfunctionalized; NS: Nonstimulated; SD: Standard deviation. 
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Figure 5. In vivo efficacy of AmB-loaded mannan-functionalized poly(d,l-lactide-co-glycolide) nanospheres in 
Leishmania-infected Balb/c mice (see facing page). One week after treatment administration, parasite burden was 
evaluated by limiting dilution assay in spleen (A) and liver (B). Profile of secreted cytokines IFN-γ (C), IL10 (D), TNF-
α (E) and nitric oxide production (F) by spleen cells isolated from differently treated Leishmania infantum-infected 
Balb/c mice, after stimulation with soluble Leishmania antigens for 96 h. Data represent mean ± SD of a 
representative experiment from three carried out independently. *p < 0.05; **p < 0.01; ***p < 0.001 when compared 
with the control group. AmB: Amphotericin B; MN: Mannan; PLGA: Poly(d,l-lactide-co-glycolide); SD: Standard 
deviation. 
 
 
 
